Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall.

Acute cell loss has been documented following angioplasty of normal rat and rabbit arteries. Here we analyzed the effects of balloon injury intensity on early cellular loss in single- and double-injury models and how it influences the efficiency of percutaneous gene delivery to the vessel wall. Rabbits underwent bilateral iliac angioplasties (n = 52) with 2.5-mm (balloon-to-artery [B/A] ratio, 1.08 to 1.13) and 3.0-mm (B/A ratio, 1.29 to 1.34) balloons. In the single-injury model, the 3.0-mm balloon induced a 61% reduction in medial cellularity at 3 days postinjury (p < 0.001) while the 2.5-mm balloon did not produce significant cell loss. In the double-injury model, the effects were more pronounced, with 35% (p < 0.01) and 91% (p < 0.001) reductions in medial cellularity at 3 days with the 2.5- and 3.0-mm balloons, respectively, but neointimal cellularity was decreased only with the 3.0-mm balloon (37% reduction, p = 0.025). Adenovirus-mediated beta-galactosidase gene delivery with a channel balloon (n = 24) revealed that larger balloon-to-artery ratios decreased both absolute levels and relative frequencies of transgene expression in the vessel wall. In the single-injury model, gene transfer efficiency was 4.2+/-1.1 and 1.3+/-0.25% (p < 0.05) for the small and large balloons, respectively. In the double-injury model, gene transfer efficiency was 6.6+/-1.6 and 2.3+/-0.8% (p < 0.05) in the neointima and 4.1+/-1.2 and 2.6+/-1.2% (p = NS) in the media for the small and large balloon, respectively. We conclude that early cell loss is dependent on the intensity of the injury in both single- and double-injury models of balloon angioplasty, with greater frequencies of cell loss occurring in the media than in the neointima. In both models, larger balloon-to-artery ratios result in disproportionate reductions in percutaneous adenovirus-mediated gene delivery.

[1]  M. Makuuchi,et al.  A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. , 2000, Journal of molecular and cellular cardiology.

[2]  R. D. Rudic,et al.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. , 2000, The Journal of clinical investigation.

[3]  K. Walsh,et al.  Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local delivery catheters. , 2000, Human gene therapy.

[4]  J. Gunn,et al.  Apoptosis and cell proliferation after porcine coronary angioplasty. , 1998, Circulation.

[5]  J. Isner,et al.  Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels. , 1998, Human gene therapy.

[6]  K. March,et al.  Gene therapy for restenosis: getting nearer the heart of the matter. , 1998, Circulation research.

[7]  T. Libermann,et al.  Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Perlman,et al.  Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. , 1997, Circulation.

[9]  J. Isner,et al.  Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. , 1997, Cardiovascular research.

[10]  R. Crystal,et al.  Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. , 1997, Circulation.

[11]  M. Perricaudet,et al.  Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. , 1997, Circulation.

[12]  A. Mahfoudi,et al.  p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. , 1997, Genes & development.

[13]  J. Isner,et al.  Histochemical staining following LacZ gene transfer underestimates transfection efficiency. , 1997, Human gene therapy.

[14]  P. Nisen,et al.  Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. , 1997, The Journal of clinical investigation.

[15]  K. Walsh,et al.  Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. , 1997, Circulation research.

[16]  K Walsh,et al.  Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. , 1997, Circulation.

[17]  Brian Salmons,et al.  Removal of an inhibitor of marker enzyme activity in artery extracts by chelating agents. , 1997, BioTechniques.

[18]  H. Browne,et al.  Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. , 1996, Circulation research.

[19]  M. Rekhter,et al.  Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. , 1996, The Journal of clinical investigation.

[20]  K. Hatakeyama,et al.  Effects of inflation pressure of balloon catheter on vascular injuries and subsequent development of intimal hyperplasia in rabbit aorta. , 1996, Atherosclerosis.

[21]  C. Borst,et al.  Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. , 1996, Journal of vascular research.

[22]  M. Adams,et al.  Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[23]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[24]  M. Condorelli,et al.  Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. , 1995, Circulation.

[25]  M. Perricaudet,et al.  Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. , 1995, The Journal of clinical investigation.

[26]  J. Seltzer,et al.  Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product , 1995, Science.

[27]  B. Trapnell,et al.  Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. , 1995, Human gene therapy.

[28]  B. A. French,et al.  Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. , 1994, Circulation.

[29]  R. Crystal,et al.  In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Nabel,et al.  Gene therapy for vascular smooth muscle cell proliferation after arterial injury. , 1994, Science.

[31]  S. Epstein,et al.  The basis of molecular strategies for treating coronary restenosis after angioplasty. , 1994, Journal of the American College of Cardiology.

[32]  J. Isner,et al.  Prospects for site-specific delivery of pharmacologic and molecular therapies. , 1994, Journal of the American College of Cardiology.

[33]  R. Crystal,et al.  Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima , 1993, Circulation.

[34]  B. Trapnell,et al.  Pharmacokinetics of adenoviral-mediated gene delivery to vascular smooth muscle cells Implications for cardiovascular gene therapy , 1993 .

[35]  R. Kernoff,et al.  Time course and cellular characteristics of the iliac artery response to acute balloon injury. An angiographic, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand white rabbit. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  B. L. Langille,et al.  Structural changes and recovery of function after arterial injury. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  E J Topol,et al.  Experimental models of coronary artery restenosis. , 1992, Journal of the American College of Cardiology.

[38]  K. Karsch,et al.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. , 1990, Circulation research.

[39]  S. Schwartz,et al.  Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.

[40]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.